Dr. Yijuang Chern: Microglial Galectin-3 and Neuroinflammation...

2024-03-31 / GlobalBio & Investment

#iPSCellRevolutionOnMarch11th(Mon.),StanfordUniversityfromtheU.S.,KaohsiungMedicalUniversity,andAcademiaSinicawilljointlyhostthe2024Stanford-TaiwanSymposiumoniPSCandRegenerativeMedicine.Inthisevent,Dr...

GBIHighlights

Dr. Ying-Chih Chang: Harnessing Biomimetic Materials to Induce Stemness in Rare Cells for...

2024-03-31 / GlobalBio & Investment

GBIHighlights

Dr. Shihhwa Chiou: Application of iPSC-based Technology on Retinal Diseases

2024-03-31 / GlobalBio & Investment

GBIHighlights

Dr. Jun-An Chen: Conducting the Neuronal Molecular Symphony

2024-03-31 / GlobalBio & Investment

GBIHighlights

Dr. Patrick Hsieh: Taiwan iPSC Bank for precision medicine and cell therapy

2024-03-31 / GlobalBio & Investment

GBIHighlights

Make a Wild Horse into a Pegasus! iPS Cells Research in Taiwan – List of Scientists!

2024-03-31 / GlobalBio & Investment

#iPSCellRevolutionThe#iPSCellRevolutionsignifiestherevolutionarydiscoveryofinducedpluripotentstemcells(iPScells)byDr.ShinyaYamanaka(山中伸弥)in2006.Sincethen,scientistsworldwidehavebeenworkinghardtoexplor...

GBIHighlights

Formosa Pharmaceuticals, Inc. has received FDA approval for their ophthalmic eye drops

2024-03-31 / GlobalBio & Investment

#FDAApprovalExcitingnews!FormosaPharmaceuticals,Inc.(6838.TWO)hasreceivedFDAapprovalfortheirhashtag#ophthalmiceyedrops,APP13007,whichareusedtotreatpost-operativeinflammationandpainfollowingeyesurgery....

GBIHighlights

Taiwan’s research and development of rare disease drugs has yielded great results!

2024-03-31 / GlobalBio & Investment

#RareDiseaseBreakthroughsAmidstthepandemic,Taiwanesepharmaceuticalcompaniesdevelopingrarediseasedrugshavereportedpositiveresultsinclinicaltrials,leadingtoremarkablegrowthintheirstocks.Over30companiesi...

GBIHighlights

BRIM Biotechnology, Inc. announced its three focus areas for this year's operations

2024-02-28 / GlobalBio & Investment

#OphthalmologyInnovationGreatnewsfromBRIMBiotechnology,Inc.(6885.TWO)!Thecompanyhasannounceditsthreefocusareasforthisyear'soperations,whichinclude:1.ContinuingthedevelopmentofBRM421,theirleadasset...

GBIHighlights

Sartorius experts highlighted the key specifications of the new PIC/S GMP Annex 1 regulation

2024-02-28 / GlobalBio & Investment

#BiotechInsightsExcitingupdatesfromSartoriusandAdimmuneCorp(4142)'scorporateseminar!Sartoriusexperts,Tse-WeiChenandRZLin,highlightedthelatesttrendsincellculturedevelopmentandthekeyspecificationsof...

GBIHighlights

AnHorn partnered with European startups to explore new treatment targets for prostate cancer

2024-02-28 / GlobalBio & Investment

#InnovativeCollaborationAnHornMedicines,anAI-drivendrugdiscoverycompanyfocusedonproteindegradation,haspartneredwithEuropeanstartupstoexplorenewtreatmenttargetsforprostatecancer.On20February2024,Anhorn...

GBIHighlights

PharmaEssentia and Oneness Biotech Co Ltd have been honored in Sustainability Yearbook 2024

2024-02-28 / GlobalBio & Investment

#ESGExcellenceExcitingnews!PharmaEssentia(TPE:6446)andOnenessBiotechCoLtd(TPE:4743)havebeenhonoredintheprestigiousSustainabilityYearbook2024byS&PGlobalRatings.PharmaEssentiamarksahistoricmomentast...